Hyperglycemic compositions
US5234906A · kind A · utility
48Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 1991 |
| Grant date | Aug 10, 1993 |
| Priority date | — |
| Expiry date | Jan 10, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions having amylin or an amylin agonist and a glucagon compound, particularly peptide compounds, for the control of glucose production in mammals are provided. The compositions are useful in the treatment of hypoglycemia, including acute hypoglycemic conditions such as those brought on by insulin overdose and the overuse of oral hypoglycemic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.